查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1687806

自動液體處理器：市場佔有率分析、行業趨勢和統計數據、成長預測（2025-2030 年）

Automated Liquid Handlers - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030)
出版日期: | 出版商: Mordor Intelligence | 英文 126 Pages | 商品交期: 2-3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

自動化液體處理器市場規模預計在 2025 年為 12.4 億美元，預計到 2030 年將達到 16.8 億美元，預測期內（2025-2030 年）的複合年成長率為 6.24%。

自動化液體處理器-市場-IMG1

由於 COVID-19 疫情爆發，全球診斷實驗室的測試、追蹤和追蹤要求增加，導致自動化液體處理市場的需求大幅增加。特別是隨著與疫情相關的樣本湧入增加，實驗室需要更強的能力來每天檢測數千個樣本。

主要亮點

  • 自動化系統的靈活性和適應性使得自動化液體處理設備在實驗室自動化中得到廣泛的應用。高效率的死體積分配縮短了處理時間並降低了樣品污染的機會。液體處理器還能夠分配納升量，使其可用於分配任務。
  • 市面上有各種各樣的自動化液體處理系統。這些是用於移液的空氣或液體填充系統，結合了固定和/或拋棄式吸頭。具有液體檢測系統的自動化平台可記錄抽吸動作，適用於少量生物分析樣本。
  • 此外，世界各地（尤其是美國）臨床試驗和臨床前試驗的迅速擴張對樣本分析的速度提出了要求。臨床研究機器持續運作，需要大量勞動力來確保正常運作。此外，現有疾病的快速傳播和新疾病的發現也推動了對早期治療和診斷的需求。預計這將增加臨床診斷的應用並刺激自動液體處理器的採用。
  • 此外，2021 年 1 月，SPT Labtech 收購了 Apricot Designs。透過此次收購，SPT 旨在擴大其液體處理技術範圍，作為結構生物學、藥物發現、樣本管理、基因組學、生物庫和低溫電子顯微鏡自動化解決方案的一部分。預計此類發展將進一步促進市場發展。
  • 對快速週轉時間 (TAT)、高吞吐量、減少人為錯誤和降低營運成本的需求不斷增加是推動採用自動化液體處理器的一些關鍵因素。液體處理器通常用於生物化學和化學實驗室。自動化液體處理機器人可幫助實驗室轉移樣本和其他液體。液體處理器使用軟體控制器和整合系統來客製化批量轉移的處理程序。
  • 此外，2021年6月，德國默克公司宣布計劃在法國投資1.75億歐元。吉倫特實驗室將投資約 5,000 萬歐元，計畫將產量提高三倍，專門研究治療癌症的生物技術藥物。
  • 此外，自動容量分配器等先進的液體處理技術允許使用者在較小的體積範圍內處理更多種類的液體，從高黏度到高揮發性。貝克曼庫爾特推出了一系列適用於基因組、細胞、蛋白質和其他工作流程的可擴展液體處理解決方案。新發布的 Biomek 4000 自動液體處理器有助於標準化您的日常移液程序，保持樣品品質並產生可重複的可靠結果。

自動化液體處理器市場趨勢

臨床診斷顯著成長

  • 醫學實驗室的自動化是一個日益成長的趨勢，包括臨床化學、血液學和分子生物學等研究和診斷實驗室。模組化實驗室自動化廣泛應用於臨床診斷的各種應用，包括樣品製備、分發、篩檢和存檔。此外，美國美國衛生研究院（NIH）對臨床研究的資助逐年增加，這是市場的主要動力。
  • 臨床診斷已被證明對感染疾病和慢性病的治療有益。根據世界衛生組織估計，心血管疾病、癌症、呼吸道疾病等慢性疾病每年導致全球約3,800萬人死亡，佔全球死亡總數的62%。
  • 此外，根據美國國立衛生研究院的數據，預計2022年臨床研究支出將達到約183.2億美國，這有望成為未來市場成長的驅動力。
  • 根據美國心臟協會統計，每天約有2,300名美國人死於心血管疾病，平均每38秒就有一人死亡。
  • 據主要企業羅氏控股稱，臨床診斷在疾病的預防、檢測和管理中發揮關鍵作用。臨床診斷僅佔醫療保健支出的 2%，但卻影響約三分之二的臨床決策。自動化臨床診斷是一個巨大的挑戰，因為它需要持續的、高品質的客戶服務。這對於獲得可靠的測試結果和確保患者安全至關重要。
  • 此外，2022 年 5 月，印度商務和工業部的資料顯示，2021-22 會計年度，印度醫院和診斷中心產業的外國直接投資 (FDI) 資本注入成長了 39%，總資本注入額達到約 6.975 億美元。

北美佔最大市場佔有率

  • 北美自動化液體處理解決方案供應商不斷創新，以整合最多的臨床設備。此外，根據基金會-Keybridge設備與軟體投資動量監測，美國臨床設備投資在2021年第二季以0.7%的年化速度成長，2021年8月與去年同期相比成長了19%。
  • 此外，美國面臨臨床實驗室技術人員和實驗室人員短缺的問題，預計將在全國範圍內率先實現檢測自動化。美國勞工統計局預測，未來幾年臨床實驗室技術人員的短缺將超過 15 萬名，而退休潮將使許多合格的工人退出勞動力市場，從而加劇短缺情況。每年約有 5,000 名美國臨床實驗室科學家進入勞動市場，不到每年滿足日益成長的服務需求所需的約 12,000 名科學家的一半。
  • 預計研發領域的發展將推動全國許多公共機構加強實驗室能力，從而增加對實驗室自動化設備的需求。例如，位於馬裡蘭州弗雷德里克市德特里克堡的美國感染疾病醫學研究所（USAMRIID）正在進行最後的試運行。該建築計劃於 2021 年投入使用。這座佔地 835,000 平方英尺的建築預計將成為美國生物防禦研究計畫的主要設施。
  • 此外，由於美國政府和美國食品藥物管理局（FDA）實施的嚴格監管，診斷市場的需求不斷成長，以及由於該地區心血管和神經系統疾病等各種疾病的增加，對藥物發現和研究實驗室的重視程度不斷提高，刺激了藥物發現和臨床診斷領域的需求。
  • 該地區新實驗室基礎設施的建設正在加速進行。例如，2021年4月，領先的高階分析測量技術供應商耶拿分析儀器公司宣佈在Endress+Hauser園區開設應用實驗室。該實驗室旨在為美國內部客戶支援和演示提供一個集中地點。實驗室將提供演示，展示耶拿分析儀器在液體處理和自動化、化學分析和生命科學領域的精確度和準確度。
  • 新軟體創新解決方案和擴展的趨勢已經轉化為區域自動化液體處理市場的需求，從而主導北美和全球市場。

自動化液體處理器產業概覽

自動化液體處理市場較為分散，只有少數知名公司，而新加入的新興企業和夥伴關係的創新正在增加市場上的新競爭對手。賽默飛世爾科技、珀金埃爾默、貝克曼庫爾特和康寧是該市場的主要參與者。產品創新、合作和收購是擴大市場佔有率的關鍵發展。

  • 2022 年 2 月 - 生命科學實驗室自動化專家 SPT Labtech 在波士頓舉行的 SLAS 2022 國際會議和展覽會上推出了四合一自動化液體處理平台 apricot DC1。本次示範將介紹一種緊湊型自動移液器，以幫助實驗室簡化日常應用中的手動和半手動移液過程。
  • 2021 年 1 月－QIAGEN NV 宣佈在全球推出 QIAcube Connect MDx，這是一個靈活的自動化樣本處理平台，可供美國、加拿大、歐盟和其他全球市場的分子診斷實驗室使用。

其他福利：

  • Excel 格式的市場預測 (ME) 表
  • 3個月的分析師支持

目錄

第1章 引言

  • 研究假設和市場定義
  • 研究範圍

第2章調查方法

第3章執行摘要

第4章 市場洞察

  • 市場概覽
  • 產業價值鏈分析
  • 產業吸引力－波特五力分析
    • 供應商的議價能力
    • 買家的議價能力
    • 新進入者的威脅
    • 競爭對手之間的競爭
    • 替代品的威脅
  • COVID-19 市場影響評估

第5章市場動態

  • 市場促進因素
    • 實驗室自動化系統的靈活性和適應性
  • 市場限制
    • 中小型組織的採用率下降

第6章市場區隔

  • 按應用
    • 藥物研發
    • 癌症和基因組研究
    • 生物技術
    • 其他用途
  • 按行業
    • 合約研究組織
    • 製藥和生物技術
    • 學術和研究機構
  • 按地區
    • 北美洲
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲

第7章競爭格局

  • 公司簡介
    • Thermo Fisher Scientific
    • Perkin Elmer Inc.
    • Danaher Corporation（Beckman Coulter Inc.）
    • Formulatrix Inc.
    • Mettler-Toledo International Inc.
    • Agilent Technologies Inc.
    • Hamilton Company
    • Becton Dickinson and Company
    • Synchron Lab Automation
    • Tecan Group Ltd
    • Aurora Biomed Inc.
    • Eppendorf AG
    • Analytik Jena AG（Endress+Hauser Group Services AG）
    • Hudson Robotics Inc.

第8章投資分析

第9章：市場的未來

簡介目錄
Product Code: 66246

The Automated Liquid Handlers Market size is estimated at USD 1.24 billion in 2025, and is expected to reach USD 1.68 billion by 2030, at a CAGR of 6.24% during the forecast period (2025-2030).

Automated Liquid Handlers - Market - IMG1

With the outbreak of COVID-19, the automated liquid handler market witnessed a significant increase in demand due to the increasing requirement for testing, tracing, and tracking in diagnostic labs globally. As the volume of incoming samples, especially related to the pandemic situation, laboratories need many capabilities to test up to thousands of samples daily.

Key Highlights

  • Automation systems' flexibility and adaptability made automated liquid handlers' equipment widely used in lab automation. They reduce processing time and the possibility of sample contamination by dispensing dead volumes efficiently. Liquid handlers can work with volumes as small as nanoliters, making them helpful in dispensing operations.
  • There is a wide range of automated liquid handling systems on the market. They are air-based or liquid-filled systems for pipetting with either/or a combination of fixed and disposable tips. Automation platforms with liquid detection systems record aspiration action and assist when bioanalytical sample volumes are low.
  • Furthermore, the rapid expansion of several clinical and pre-clinical studies worldwide, particularly in the United States, has created a need for speed in sample analysis. The machines in clinical studies run continuously and require a large workforce to ensure proper operation. Furthermore, the rapid spread of existing diseases and the discovery of new diseases raises the demand for early treatments and diagnoses. This is expected to boost the rate of clinical diagnostic application, fueling the adoption of automated liquid handlers.
  • Furthermore, in January 2021, SPT Labtech acquired Apricot Designs. Through this purchase, SPT aimed to extend its range of liquid handling technologies as part of its collection of automation resolutions for structural biology, drug discovery, sample managing, genomics, biobanking, and cryo-electron microscopy. Such developments are anticipated to further drive the market growth.
  • The increasing need for faster turn-around times (TAT), higher throughput, reduced human errors, and lower operational costs are some of the major factors driving the adoption of automated liquid handlers. Liquid handlers are typically employed in biochemical and chemical laboratories. Automatic liquid handling robots aid in the dispensing of samples and other liquids in laboratories. Liquid handlers use a software controller and an integrated system to customize handling procedures for large transfer volumes.
  • Further, in June 2021, the German laboratory Merck announced its plan to invest EUR 175 million in France. About EUR 50 million was invested in the Gironde laboratory, which planned to triple its production, specializing in drugs derived from biotechnologies to treat cancer.
  • Furthermore, advanced liquid handling technologies, such as automatic positive displacement pipetting systems, allow users to handle highly viscous to highly volatile liquids in lower volume ranges and with a broader range of liquid types. Beckman Coulter has introduced a new line of scalable liquid handling solutions for genomic, cellular, protein, and other workflows. The newly released Biomek 4000 Automated Liquid Handler aids in standardizing daily pipetting routines, preserving sample quality, and generating repeatable and reliable results.

Automated Liquid Handlers Market Trends

Clinical Diagnostics to Witness Significant Growth

  • Automation in medical laboratories has been witnessing an increasing trend, including research and diagnostic laboratories, such as clinical chemistry, hematology, and molecular biology. Modular laboratory automation is widely employed in clinical diagnostics for various applications that include sample preparation, distribution, screening, and archiving. Further, year to year, growth in funding provided by NIH (National Institutes of Health) in clinical research is significantly driving the market.
  • Clinical diagnostics have been proven beneficial in treating infectious and chronic disease conditions. World health organization (WHO) estimates that chronic disease conditions, like cardiovascular diseases, cancer, and respiratory diseases, are responsible for about 38 million people every year, accounting for 62% of all deaths worldwide.
  • Moreover, according to the National Institutes of Health, clinical research funding in 2022 is expected to be around 18.32 billion US dollars, which is expected to drive market growth in the future.
  • Statistics from American Heart Association indicate that about 2,300 Americans die of cardiovascular diseases each day, an average of 1 death every 38 seconds, thus indicating the need to treat them and find a solution via clinical diagnostics research.
  • According to Roche Holding AG, a leading pharmaceutical company, clinical diagnostics play a crucial role in disease prevention, detection, and management. Though they account for just 2% of healthcare spending, they influence roughly two-thirds of clinical decision-making. Implementation of automation for clinical diagnostics is quite challenging as the processes need continuous, high-quality customer service. This is very important to obtain reliable test results and to provide patient safety.
  • Further, in May 2022, according to data from the Ministry of Commerce and Industry, the hospitals and diagnostic centers sector in India experienced a 39% increase in Foreign Direct Investment (FDI) fund infusion during the fiscal year 2021-22, with fund infusion totaling approximately USD 697.5 million, this is expected to provide positive boost to the market growth.

North America Accounts For Largest Market Share

  • Automated liquid handling solution providers in North America continuously innovate to integrate a maximum number of clinical equipment. Further, according to the Foundation-Keybridge Equipment & Software Investment Momentum Monitor, US investment in clinical equipment increased at a 0.7% annualized rate in Q2 2021 and was up 19% year over year in August 2021.
  • Besides, the United States faces a shortfall in laboratory scientists and lab personnel, which is expected to spearhead lab automation across the country. The Department of Labor and Statistics predicts a future shortage of more than 150,000 clinical laboratory scientists exacerbated by a wave of retirements that would see much-qualified personnel leave the workforce over the coming years. Around 5,000 American lab professionals enter the labor pool each year, less than half of the approximately 12,000 workers a year necessary to meet the rising demand for their services.
  • Due to the developments in the field of R&D, many public institutions are expected to enhance their laboratory capabilities across the country, boosting the demand for lab automation equipment. For instance, final commissioning is underway at the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID) in Fort Detrick in Frederick, Maryland. The building is anticipated to be open for occupancy in 2021. This 835,000-square-foot building is expected to serve as the lead facility for the U.S. Biological Defense Research Program.
  • Furthermore, strict regulations imposed by the U.S. government and the FDA, along with the growing demand in the diagnostic market with the increasing emphasis on drug discovery and research laboratories owing to the rising presence of various diseases such as cardiovascular diseases and neurological diseases in the region, fueled the demand of drug discovery and clinical diagnostics sector.
  • New lab infrastructure setup has been accelerated in the region. For instance, in April 2021, Analytik Jena, a leading provider of high-end analytical measuring technology, announced the opening of its applications lab within the Endress+Hauser campus. The lab aimed to offer a centralized location in the United States for in-house customer support and demonstrations. This lab is set to provide demos to showcase the precision and accuracy of Analytik Jena instruments in liquid handling and automation, chemical analysis, and life science groups.
  • The trend towards new software innovation solutions and expansion has translated the demand for automated liquid handlers market in the region, leading to dominating the North American and the global markets.

Automated Liquid Handlers Industry Overview

The Automated Liquid Handlers Market is moderately fragmented due to the presence of a few prominent players, and newly added startups and partnership innovations are increasing new rivalry in the market. Thermo Fisher Scientific, Perkin Elmer Inc., Beckman Coulter Inc., Corning Inc., and others are key market players. Product innovation, partnerships, and acquisition are vital developments to increase their market share.

  • February 2022 - SPT Labtech, a laboratory automation specialist for life sciences, debuted the apricot DC1, a 4-in-1 automated liquid handling platform, at the SLAS 2022 International Conference and Exhibition in Boston. The launch introduces a compact automatic pipettor to help laboratories streamline daily manual or semi-manual pipetting processes across applications.
  • Match 2021 - QIAGEN N.V. announced the global launch of the QIAcube Connect MDx, a flexible platform for automated sample processing available to molecular diagnostic laboratories in the U.S. and Canada, the European Union, and other markets worldwide.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET INSIGHTS

  • 4.1 Market Overview
  • 4.2 Industry Value Chain Analysis
  • 4.3 Industry Attractiveness - Porter's Five Forces Analysis
    • 4.3.1 Bargaining Power of Suppliers
    • 4.3.2 Bargaining Power of Buyers
    • 4.3.3 Threat of New Entrants
    • 4.3.4 Intensity of Competitive Rivalry
    • 4.3.5 Threat of Substitutes
  • 4.4 Assessment of the Impact of COVID-19 on the Market

5 MARKET DYNAMICS

  • 5.1 Market Drivers
    • 5.1.1 Flexibility and Adaptability of Lab Automation Systems
  • 5.2 Market Restraints
    • 5.2.1 Slower Adoption Rates in Small- and Medium-sized Organizations

6 MARKET SEGMENTATION

  • 6.1 By Application
    • 6.1.1 Drug Discovery
    • 6.1.2 Cancer and Genomic Research
    • 6.1.3 Biotechnology
    • 6.1.4 Other Applications
  • 6.2 By End-user Vertical
    • 6.2.1 Contract Research Organizations
    • 6.2.2 Pharmaceutical and Biotechnology
    • 6.2.3 Academic and Research Institutes
  • 6.3 By Geography
    • 6.3.1 North America
    • 6.3.2 Europe
    • 6.3.3 Asia Pacific
    • 6.3.4 Latin America
    • 6.3.5 Middle East and Africa

7 COMPETITIVE LANDSCAPE

  • 7.1 Company Profiles
    • 7.1.1 Thermo Fisher Scientific
    • 7.1.2 Perkin Elmer Inc.
    • 7.1.3 Danaher Corporation (Beckman Coulter Inc.)
    • 7.1.4 Formulatrix Inc.
    • 7.1.5 Mettler-Toledo International Inc.
    • 7.1.6 Agilent Technologies Inc.
    • 7.1.7 Hamilton Company
    • 7.1.8 Becton Dickinson and Company
    • 7.1.9 Synchron Lab Automation
    • 7.1.10 Tecan Group Ltd
    • 7.1.11 Aurora Biomed Inc.
    • 7.1.12 Eppendorf AG
    • 7.1.13 Analytik Jena AG (Endress+Hauser Group Services AG)
    • 7.1.14 Hudson Robotics Inc.

8 INVESTMENT ANALYSIS

9 FUTURE OF THE MARKET